A proteomic investigation of isogenic radiation resistant prostate cancer cell lines-Reference-Cited by-同舟云学术

A proteomic investigation of isogenic radiation resistant prostate cancer cell lines

Published:2021-06-30 Issue:5 Volume:15 Page:2100037
ISSN:1862-8346
Container-title:PROTEOMICS – Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Kurganovs Natalie¹,Wang Hanzhi²³,Huang Xiaoyong²,Ignatchenko Vladimir¹,Macklin Andrew¹,Khan Shahbaz¹,Downes Michelle R.⁴⁵,Boutros Paul C.⁶⁷^ORCID,Liu Stanley K.²^ORCID,Kislinger Thomas¹³^ORCID

Affiliation:

1. Princess Margaret Cancer Centre University Health Network Toronto Canada

2. Sunnybrook Research Institute Sunnybrook Health Sciences Centre Toronto Canada

3. Department of Medical Biophysics University of Toronto Toronto Canada

4. Division of Anatomic Pathology Laboratory Medicine and Molecular Diagnostics Sunnybrook Health Sciences Centre Toronto Canada

5. Department of Laboratory Medicine and Pathobiology University of Toronto Toronto Canada

6. Departments of Human Genetics & Urology Jonsson Comprehensive Cancer Center Los Angeles USA

7. Institute for Precision Health University of California Los Angeles USA

Funder

National Cancer Institute

Prostate Cancer Canada

Publisher

Wiley

Subject

Clinical Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prca.202100037

Reference59 articles.

1. Cancer statistics, 2020

2. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

3. Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

4. A Systematic Review of Hypofractionation for Primary Management of Prostate Cancer

5. Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer;BJC Reports;2024-08-21

2. Organelle resolved proteomics uncovers PLA2R1 as a novel cell surface marker required for chordoma growth;Acta Neuropathologica Communications;2024-03-07

3. Hypofractionated Radiation Versus Conventional Fractionated Radiation: A Network Analysis;Journal of Lasers in Medical Sciences;2022-09-23

4. Antagonizing Glutamine Bioavailability Promotes Radiation Sensitivity in Prostate Cancer;Cancers;2022-05-19